MIDAS (Modafinil in Debilitating Fatigue After Stroke): A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Trial

BACKGROUND AND PURPOSE—: This study aimed to assess the efficacy of modafinil, a wakefulness-promoting agent in alleviating post-stroke fatigue ≥3 months after stroke. We hypothesized that 200 mg of modafinil daily for 6 weeks would result in reduced symptoms of fatigue compared with placebo. METHOD...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Stroke
Main Authors: Bivard, Andrew, Lillicrap, Thomas, Krishnamurthy, Venkatesh, Holliday, Elizabeth, Attia, John, Pagram, Heather, Nilsson, Michael, Parsons, Mark, Levi, Christopher R.
Formato: Artigo
Idioma:Inglês
Publicado em: Lippincott Williams & Wilkins 2017
Assuntos:
Original Contributions
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5404401/
https://ncbi.nlm.nih.gov/pubmed/28404841
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/STROKEAHA.116.016293
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados